Autism Study Focuses On Chromosome 16 And Discovers 100-Fold Greater Prevalence science20.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science20.com Daily Mail and Mail on Sunday newspapers.
Vertex Is Writing A New Playbook For Pharma R&D And It s Working forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
BOSTON (BUSINESS WIRE) Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Charles Wagner, Executive Vice President and Chief Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer, will participate in two upcoming investor c.
David Altshuler, EVP, Global Research and CSO of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 4,002 shares of the company on February 20, 2024, according to a recent SEC filing.